FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?

Eli Lilly (NYSE: LLY) has been experiencing fantastic growth due to the success of its GLP-1 drugs, Mounjaro (approved for ...

Eli Lilly bid to expand Mounjaro label declined in EU

Eli Lilly (LLY) stock in focus as EU drug regular declines to endorse heart failure as a new indication for the company's GLP ...

Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch

Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the ...

Eli Lilly Expands Beyond GLP 1 With New Deals And Cancer Win

Eli Lilly (NYSE:LLY) announced a collaboration with Repertoire Immune Medicines to develop next generation autoimmune ...
Technical.ly

Eli Lilly expands Southeast PA presence with $3.5B drug manufacturing facility

Eli Lilly is expanding its footprint in eastern Pennsylvania with a new manufacturing site outside of Philadelphia. The global pharmaceutical company revealed plans today to build a $3.5 billion drug ...

Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data

On Tuesday, we'll get the latest from names including Pfizer, Pepsi, Merck, Advanced Micro Devices, and Chipotle . While ...

Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless

By Mariam Sunny and Bhanvi Satija Jan 28 (Reuters) - U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion ...